• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

轻度肥胖患者在七氟烷麻醉期间及麻醉后的血清无机氟水平。

Serum inorganic fluoride levels in mildly obese patients during and after sevoflurane anesthesia.

作者信息

Higuchi H, Satoh T, Arimura S, Kanno M, Endoh R

机构信息

Department of Anesthesiology, National Defense Medical College, Saitama, Japan.

出版信息

Anesth Analg. 1993 Nov;77(5):1018-21. doi: 10.1213/00000539-199311000-00025.

DOI:10.1213/00000539-199311000-00025
PMID:8214701
Abstract

Serum inorganic fluoride levels in obese versus control patients were compared during and after sevoflurane anesthesia. Mean serum inorganic fluoride levels in the obese group increased more rapidly and were significantly higher than in the control group at each sampling time (P < 0.01). The area under the curve of fluoride concentration, versus time up to 24 h and 48 h in the obese patients, was significantly greater than that in the nonobese patients (P < 0.001). Peak serum fluoride level in the obese patients was 51.7 +/- 2.5 mumol/L and exceeded 50 mumol/L for nearly 2 h. Our study showed that serum fluoride concentrations between mildly obese and nonobese patients differed during and after sevoflurane anesthesia.

摘要

在七氟醚麻醉期间及之后,对肥胖患者与对照患者的血清无机氟水平进行了比较。肥胖组的平均血清无机氟水平上升更快,且在每个采样时间均显著高于对照组(P < 0.01)。肥胖患者在24小时和48小时内氟化物浓度与时间曲线下的面积显著大于非肥胖患者(P < 0.001)。肥胖患者的血清氟峰值水平为51.7 +/- 2.5 μmol/L,且超过50 μmol/L近2小时。我们的研究表明,在七氟醚麻醉期间及之后,轻度肥胖患者与非肥胖患者的血清氟浓度存在差异。

相似文献

1
Serum inorganic fluoride levels in mildly obese patients during and after sevoflurane anesthesia.轻度肥胖患者在七氟烷麻醉期间及麻醉后的血清无机氟水平。
Anesth Analg. 1993 Nov;77(5):1018-21. doi: 10.1213/00000539-199311000-00025.
2
Plasma inorganic fluoride levels with sevoflurane anesthesia in morbidly obese and nonobese patients.病态肥胖和非肥胖患者七氟醚麻醉下的血浆无机氟水平。
Anesth Analg. 1993 Jun;76(6):1333-7. doi: 10.1213/00000539-199376060-00026.
3
Sevoflurane versus isoflurane for maintenance of anesthesia: are serum inorganic fluoride ion concentrations of concern?七氟烷与异氟烷用于维持麻醉:血清无机氟离子浓度是否值得关注?
Anesth Analg. 1996 Jun;82(6):1268-72. doi: 10.1097/00000539-199606000-00029.
4
Serum and urinary inorganic fluoride concentrations after prolonged inhalation of sevoflurane in humans.
Anesth Analg. 1992 May;74(5):753-7. doi: 10.1213/00000539-199205000-00022.
5
Serum and urine inorganic fluoride levels following prolonged low-dose sevoflurane anesthesia combined with epidural block.长时间低剂量七氟醚麻醉联合硬膜外阻滞术后血清及尿液中无机氟水平
J Clin Anesth. 1994 Sep-Oct;6(5):419-24. doi: 10.1016/s0952-8180(05)80015-7.
6
[Serum and urinary inorganic fluoride levels after prolonged inhalation of sevoflurane in man].[人体长时间吸入七氟醚后血清及尿中无机氟水平]
Masui. 1992 Jun;41(6):956-63.
7
Plasma inorganic fluoride with sevoflurane anesthesia: correlation with indices of hepatic and renal function.七氟烷麻醉下的血浆无机氟化物:与肝肾功能指标的相关性
Anesth Analg. 1992 Feb;74(2):231-5. doi: 10.1213/00000539-199202000-00010.
8
Urinary excretion of inorganic and organic fluoride after inhalation of sevoflurane.吸入七氟醚后无机氟和有机氟的尿排泄情况。
Hiroshima J Med Sci. 1987 Mar;36(1):99-104.
9
Comparison of plasma inorganic fluoride concentration with sevoflurane-N2O and enflurane-N2O anesthesia.七氟醚 - 氧化亚氮与安氟醚 - 氧化亚氮麻醉下血浆无机氟浓度的比较。
Yonsei Med J. 1994 Jun;35(2):218-22. doi: 10.3349/ymj.1994.35.2.218.
10
[Serum inorganic fluoride concentrations and their urinary excretion during and after sevoflurane, isoflurane, or enflurane anesthesia in man].[人体在七氟烷、异氟烷或恩氟烷麻醉期间及之后的血清无机氟浓度及其尿排泄情况]
Masui. 1993 Apr;42(4):562-7.

引用本文的文献

1
Higher chlorzoxazone clearance in obese children compared with nonobese peers.肥胖儿童的氯唑沙宗清除率高于非肥胖同龄人。
Br J Clin Pharmacol. 2018 Aug;84(8):1738-1747. doi: 10.1111/bcp.13602. Epub 2018 Jun 3.
2
Studies of the mechanism of nephrotoxicity of compound A in rats.化合物A对大鼠肾毒性机制的研究。
J Anesth. 1997 Mar;11(1):32-37. doi: 10.1007/BF02480002.
3
Impact of obesity on drug metabolism and elimination in adults and children.肥胖对成人和儿童药物代谢和消除的影响。
Clin Pharmacokinet. 2012 May 1;51(5):277-304. doi: 10.2165/11599410-000000000-00000.
4
Application of a systems approach to the bottom-up assessment of pharmacokinetics in obese patients: expected variations in clearance.系统方法在肥胖患者药代动力学自下而上评估中的应用:清除率的预期变化。
Clin Pharmacokinet. 2011 Dec 1;50(12):809-22. doi: 10.2165/11594420-000000000-00000.
5
Urinary sevoflurane and hexafluoro-isopropanol as biomarkers of low-level occupational exposure to sevoflurane.尿中七氟烷和六氟异丙醇作为七氟烷低水平职业暴露的生物标志物。
Int Arch Occup Environ Health. 2005 Jun;78(5):369-78. doi: 10.1007/s00420-004-0580-8. Epub 2005 Apr 30.
6
Sevoflurance: approaching the ideal inhalational anesthetic. a pharmacologic, pharmacoeconomic, and clinical review.七氟烷:迈向理想的吸入性麻醉剂。药理学、药物经济学及临床综述。
CNS Drug Rev. 2001 Spring;7(1):48-120. doi: 10.1111/j.1527-3458.2001.tb00190.x.
7
Clinical pharmacokinetics of sevoflurane.七氟烷的临床药代动力学
Clin Pharmacokinet. 1999 Jan;36(1):13-26. doi: 10.2165/00003088-199936010-00002.
8
Sevoflurane. A review of its pharmacodynamic and pharmacokinetic properties and its clinical use in general anaesthesia.七氟烷。其药效学和药代动力学特性及其在全身麻醉中的临床应用综述。
Drugs. 1996 Apr;51(4):658-700. doi: 10.2165/00003495-199651040-00009.